CD274 and cancer: However, in some cancer types, such as non-small cell lung cancer (NSCLC) (60), classical Hodgkin’s lymphoma (cHL) (25), and urothelial carcinoma (UC) (61), PD-L1 expression did not explicitly correlate with response to pembrolizumab.